All News about Supernus Pharm
![](https://ml.globenewswire.com/media/1fc58442-511b-40c2-a8c0-f1e78b8437b4/small/supernus-pharmaceuticals-inc.jpg)
Supernus Enters Into $150 Million Credit Facility
February 14, 2023
Via GlobeNewswire
![](https://ml.globenewswire.com/media/1fc58442-511b-40c2-a8c0-f1e78b8437b4/small/supernus-pharmaceuticals-inc.jpg)
![](https://i0.wp.com/raygent.com/wp-content/uploads/2023/02/image.png)
When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader?
February 05, 2023
Via Talk Markets
![](https://cdn.benzinga.com/files/images/story/2022/10/10/aapharma_3.png?width=1200&height=800&fit=crop)
FDA Rejects Supernus Pharma's Minimally Invasive Parkinson's Therapy
October 10, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/earnings_image_2119.jpeg)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_22686.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/1fc58442-511b-40c2-a8c0-f1e78b8437b4/small/supernus-pharmaceuticals-inc.jpg)
![](https://ml.globenewswire.com/media/1fc58442-511b-40c2-a8c0-f1e78b8437b4/small/supernus-pharmaceuticals-inc.jpg)
Supernus to Present at Two November Healthcare Conferences
November 08, 2022
Via GlobeNewswire
![](https://ml.globenewswire.com/media/1fc58442-511b-40c2-a8c0-f1e78b8437b4/small/supernus-pharmaceuticals-inc.jpg)
Supernus Announces Third Quarter 2022 Financial Results
November 08, 2022
Via GlobeNewswire
![](https://ml.globenewswire.com/media/1fc58442-511b-40c2-a8c0-f1e78b8437b4/small/supernus-pharmaceuticals-inc.jpg)
![](https://ml.globenewswire.com/media/1fc58442-511b-40c2-a8c0-f1e78b8437b4/small/supernus-pharmaceuticals-inc.jpg)
Supernus Provides Regulatory Update on SPN-830
October 10, 2022
Via GlobeNewswire
![](https://cdn.pixabay.com/photo/2016/11/27/21/42/stock-1863880__340.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/10/02/biotech13.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.pixabay.com/photo/2019/12/12/08/13/space-4690045__480.jpg)
![](https://ml.globenewswire.com/media/1fc58442-511b-40c2-a8c0-f1e78b8437b4/small/supernus-pharmaceuticals-inc.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/05/01/biotech6.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/04/29/lab-5740505_1920.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/04/24/biotech2.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/roce_image_927.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU2.jpg)
![](https://cdn.benzinga.com/files/images/story/2012/pexels-pavel-danilyuk-8442380.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/biotech3_3.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cells-1872666_1920_102.jpg)
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template.jpg)
Supernus Pharmaceuticals, inc (SUPN) Q3 2021 Earnings Call Transcript
November 04, 2021
Via The Motley Fool
Topics
Earnings
Exposures
Financial
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/earnings_image_548.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_383.jpg)
The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
November 03, 2021
Via Benzinga
Topics
Retirement
Exposures
Pension
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.